XANAX Drug Patent Profile
✉ Email this page to a colleague
When do Xanax patents expire, and what generic alternatives are available?
Xanax is a drug marketed by Upjohn and is included in two NDAs.
The generic ingredient in XANAX is alprazolam. There are fifteen drug master file entries for this compound. Thirty-seven suppliers are listed for this compound. Additional details are available on the alprazolam profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Xanax
A generic version of XANAX was approved as alprazolam by NOVITIUM PHARMA on October 19th, 1993.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for XANAX?
- What are the global sales for XANAX?
- What is Average Wholesale Price for XANAX?
Summary for XANAX
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Finished Product Suppliers / Packagers: | 7 |
Raw Ingredient (Bulk) Api Vendors: | 53 |
Patent Applications: | 4,083 |
Drug Prices: | Drug price information for XANAX |
Drug Sales Revenues: | Drug sales revenues for XANAX |
What excipients (inactive ingredients) are in XANAX? | XANAX excipients list |
DailyMed Link: | XANAX at DailyMed |
Pharmacology for XANAX
Drug Class | Benzodiazepine |
US Patents and Regulatory Information for XANAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Upjohn | XANAX | alprazolam | TABLET;ORAL | 018276-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Upjohn | XANAX XR | alprazolam | TABLET, EXTENDED RELEASE;ORAL | 021434-003 | Jan 17, 2003 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Upjohn | XANAX | alprazolam | TABLET;ORAL | 018276-004 | Nov 27, 1985 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for XANAX
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Upjohn | XANAX | alprazolam | TABLET;ORAL | 018276-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | XANAX | alprazolam | TABLET;ORAL | 018276-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | XANAX | alprazolam | TABLET;ORAL | 018276-002 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for XANAX
See the table below for patents covering XANAX around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Switzerland | 548408 | VERFAHREN ZUR HERSTELLUNG VON 8-NITRO-6-(O-HALOGENPHENYL)1-METHYL-4H-S-TRIAZOLO(4,3-A)(1,4)-BENZOBENZODIAZEPINEN. (S-triazolo (4,3-a) (1,4) benzodiazepines - as sedatives, hypnotics, tranquillisers, muscle relaxants) | ⤷ Sign Up |
Yugoslavia | 34570 | ⤷ Sign Up | |
Sweden | 387641 | ANALOGIFORFARANDE FOR FRAMSTELLNING AV S-TRIAXOLO(4,3-A)(1,4)BENSODIAZEPINER | ⤷ Sign Up |
>Country | >Patent Number | >Title | >Estimated Expiration |